JonesTrading Remains Bullish on Janux Therapeutics (JANX) With a $90 Price Target
A rack of test tubes and beakers being stirred in a laboratory, as researchers analyze the data.
Janux Therapeutics, Inc. (NASDAQ:JANX) is expected to release additional data from its Phase 1 trials for JANX007 and JANX008 in H2 2025, which the analyst projects could affect its market position.
JANX007, a T cell-engaging antibody, is expected to be in competition with Pluvicto. Despite a complicated administration, Pluvicto already holds a considerable market share. However, the analyst reasoned that JANX007 could experience faster market adoption if it exhibits efficacy comparable to Pluvicto, which would positively impact Janux Therapeutics, Inc. (NASDAQ:JANX).
The analyst also noted that the safety profile of JANX007 would be critical, especially in regard to steroid use post-CRS resolution. Therefore, Roy reasoned that investor interest could grow with a favorable safety outcome.
Janux Therapeutics, Inc. (NASDAQ:JANX) is a preclinical stage biopharmaceutical company that develops therapeutics based on the Tumor Activated T Cell Engager platform technology. The company develops tumor-activated immunotherapies for cancer through two bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr).
While we acknowledge the potential of JANX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
GDEV Sends Cash Back to Investors with Special Payout
GDEV Inc. (NASDAQ:GDEV) is included among the 14 Stocks that Paid Special Dividends in 2025. A gaming enthusiast in front of a widescreen monitor, lost in the game. GDEV Inc. (NASDAQ:GDEV) is a gaming and entertainment holding company dedicated to expanding and developing its portfolio of game franchises across multiple genres and platforms. Through its subsidiaries— such as Nexters and Cubic Games— it aims to produce games that captivate and entertain millions of players over the long term. Its popular titles, including Hero Wars, Island Hoppers, and Pixel Gun 3D, have collectively surpassed 550 million downloads and generated $2.5 billion in global bookings. On February 21, GDEV Inc. (NASDAQ:GDEV) announced that its Board of Directors had approved a one-time special cash dividend of $3.31 per share. This payout represents roughly a 20% yield, based on the volume-weighted average share price over the previous 30 trading days. The special dividend, amounting to around $60 million in total, will be funded using profits the company has accumulated in recent years. It represents part of GDEV's total cash holdings, which stood at approximately $153 million as of the third quarter of 2024. While we acknowledge the potential of GDEV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
10 minutes ago
- Yahoo
Does IGIC Pay a Special Dividend?
International General Insurance Holdings Ltd. (NASDAQ:IGIC) is included among the 14 Stocks that Paid Special Dividends in 2025. An engineer wearing protective equipment, inspecting a large construction project. International General Insurance Holdings Ltd. (NASDAQ:IGIC) is a specialty insurance provider that offers coverage for both long-tail and short-tail risks, along with reinsurance services. By focusing on niche and complex markets with limited competition, IGI is able to maintain a strong position in underwriting. The company follows a careful and disciplined risk selection strategy, which has consistently led to performance that exceeds industry standards. Its combined ratio has remained well under 100%, supporting sustained profitability over the long term. In March, International General Insurance Holdings Ltd. (NASDAQ:IGIC) declared a special dividend of $0.025 per share, in addition to the company's regular dividend. On May 15, the company declared a 100% hike in its quarterly dividend to $0.05 per share. It remained committed to its shareholder obligation, returning $43.5 million to investors through regular and supplemental dividends in the first quarter of 2025. International General Insurance Holdings Ltd. (NASDAQ:IGIC) has a dividend yield of 0.83%, as recorded on July 23. While we acknowledge the potential of IGIC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Yahoo
20 minutes ago
- Yahoo
Viomi Technology (VIOT) Issues Special Dividend: What Investors Need to Know
Viomi Technology Co., Ltd (NASDAQ:VIOT) is included among the 14 Stocks that Paid Special Dividends in 2025. A customer in an offline experience store testing out a new small appliance. Viomi Technology Co., Ltd (NASDAQ:VIOT) , a prominent provider of home water solutions in China, revealed on July 14 that its board of directors has approved a special dividend of $0.0293 per ordinary share, or $0.0880 per American depositary share (ADS). The total value of this special dividend is expected to be around $6 million. Mr. Xiaoping Chen, Founder and CEO of Viomi Technology Co., Ltd (NASDAQ:VIOT), shared that after successfully completing a strategic business restructuring in 2024, the company had intensified its focus on home water solutions and moved forward with its 'Global Water' strategy. He noted that the launch of the Kunlun 4 Pro Alkaline Mineral Water Purifier marked a significant step, introducing mildly alkaline mineral water to customers and aiming to shift household standards from purified water to purified mineral water. Alongside this, Viomi Technology Co., Ltd (NASDAQ:VIOT) had been improving operational efficiency within China while expanding internationally, which contributed to notable progress. He also mentioned that with consistent business growth, the company had managed to turn its operations around, marking an important achievement in its journey. While we acknowledge the potential of VIOT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
